查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1813504

肌萎缩侧索硬化症 (ALS) 市场分析及预测（至 2034 年）：类型、产品、服务、技术、组件、应用、设备、流程和最终用户

Amyotrophic Lateral Sclerosis Market Analysis and Forecast to 2034: Type, Product, Services, Technology, Component, Application, Device, Process, End User
出版日期: | 出版商: Global Insight Services | 英文 304 Pages | 商品交期: 3-5个工作天内

价格
简介目录

肌萎缩侧索硬化症 (ALS) 市场预计将从 2024 年的 12 亿美元增至 2034 年的 21 亿美元，复合年增长率约为 5.8%。肌萎缩侧索硬化症 (ALS) 市场涵盖用于治疗 ALS（一种进行性神经退化性疾病）的药物、诊断产品和支持性治疗。基因治疗、新药研发和科研经费的不断增加推动了该市场的发展。认知度的提高和诊断技术的进步正在推动对创新疗法的需求。专注于延长患者生命和改善患者生活品质的策略合作和监管支援正在进一步推动市场成长。

肌萎缩侧索硬化症 (ALS) 市场正经历着蓬勃发展，这得益于治疗方案的进步和诊断创新。治疗领域占首位，主要得益于疾病修正治疗疗法和对症疗法。创新药物配方和新型治疗层级正在推动该领域的扩张。诊断领域表现第二佳，主要得益于生物标记技术和基因检测的显着进步。这些技术创新正在增强早期诊断和个人化治疗的方法。研发活动正在加强，尤其是在神经保护剂和再生医学领域。新型生物技术和基因疗法正日益受到关注，预计将改变 ALS 治疗的模式。人工智慧在药物研发和病患管理的应用进一步提升了成长前景。製药公司和研究机构之间的合作正在促进创新，并加速有效解决方案的开发。人们对 ALS 的认识和倡导日益增强，也推动了对先进医疗解决方案的需求不断增长。

市场区隔
类型 散发性 ALS、遗传性ALS
产品 Riluzole、Edaravone、替拉西酮、nuedexta、马赛替尼
服务 病患支援服务、咨询服务与临床试验服务
科技 生物技术、药物基因体学、基因治疗、干细胞治疗
成分 原料药、辅料
目的 医院、门诊手术中心及研究机构
装置 非侵入性通气、经皮视镜胃造口术
流程 药物开发、临床试验、核准和商业化
最终用户 医疗保健提供者、患者和製药公司

市场概述

肌萎缩侧索硬化症 (ALS) 市场正在发生动态变化，主要企业占据了显着的市场份额。定价策略正随着竞争压力和病患需求而不断发展，创新定价模式也不断涌现。生物技术的进步和对疾病机制的深入了解正在推动市场推出新产品。这些发展正在增加治疗选择、改善患者预后并塑造竞争格​​局。竞争基准基准化分析揭示了主要企业之间的激烈竞争，而策略伙伴关係和联盟正在塑造市场动态。北美和欧洲的监管机构正在实施严格的指导方针，影响市场进入和扩大策略。 ALS 市场的特点是研发投入高，重点是新疗法和个人化医疗。此外，专利到期和学名药的进入进一步使竞争格局复杂化，预计这将改变竞争平衡并推动市场发展。

主要趋势和驱动因素

在研发和治疗方法方法不断进步的推动下，肌萎缩侧索硬化症 (ALS) 市场不断发展。神经病学研究资金的增加促进了创新治疗方法的发现。新药核准和临床试验正在扩大治疗方法选择，以解决 ALS 治疗中未满足的医疗需求。个人化医疗的兴起是一个关键趋势，基因检测可以根据个别患者情况进行标靶治疗。这种方法提高了治疗效果和患者预后。製药公司和研究机构之间的合作正在加快技术创新的步伐。包括远端医疗和远端监控在内的数位健康技术正在改变患者管理并提高医疗服务的可及性。这些技术促进了即时数据收集，增强了疾病追踪和干预策略。对孤儿药开发的监管支持和激励措施正在创造有利于市场成长的环境。随着相关人员利用这些趋势推动诊断、治疗和患者照护的进步，ALS 市场将迎来扩张。

阻碍因素与挑战：

肌萎缩侧索硬化症 (ALS) 市场面临多种市场限制和挑战。一个主要阻碍因素是药物开发和临床试验的高成本。这种经济负担限制了新进入者并减缓了创新的步伐。此外，ALS 是一种罕见疾病，限制了符合临床试验条件的患者数量，使患者招募过程复杂化并延长了时间。另一个挑战是缺乏明确的诊断测试。这会导致诊断和治疗开始的延迟，影响患者的预后。 ALS 的复杂病理也阻碍了有效治疗方法的发展。研究人员难以理解该疾病的潜在机制。此外，监管障碍和新疗法的严格核准程序延误了市场进入。医疗专业人员和公众也非常需要意识提升和教育。这些知识差距可能会阻碍早期诊断和早期疗育，影响整体市场成长。

关键人物

BrainStorm Cell Therapeutics、田边三菱製药株式会社、Orphazyme、AB Science、MediciNova、Biogen、Ionis Pharmaceuticals、Cytokinetics、Amylyx Pharmaceuticals、Apellis Pharmaceuticals、Anelixis Therapeutics、Treeharmway、Genervon Biopaceutical

目录

第 1 章。肌萎缩侧索硬化症市场概述

  • 调查目的
  • 肌萎缩侧索硬化症市场定义与研究范围
  • 报告限制
  • 调查年份和货币
  • 调查方法

第二章执行摘要

第三章：重要考察

第四章肌萎缩侧索硬化症市场展望

  • 肌萎缩侧索硬化症市场细分
  • 市场动态
  • 波特五力分析
  • PESTLE分析
  • 价值链分析
  • 4P模型
  • 安索夫矩阵

第五章肌萎缩侧索硬化症市场策略

  • 母市场分析
  • 供需分析
  • 消费者购买兴趣
  • 案例研究分析
  • 定价分析
  • 监管状况
  • 供应链分析
  • 竞争产品分析
  • 近期动态

第六章肌萎缩侧索硬化症市场规模

  • 肌萎缩侧索硬化症市场规模（以价值计算）
  • 肌萎缩侧索硬化症市场规模

7. 肌萎缩侧索硬化症市场（按类型）

  • 市场概况
  • 散发性 ALS
  • 遗传性肌萎缩性侧索硬化症
  • 其他的

8. 肌萎缩侧索硬化症市场（按产品）

  • 市场概况
  • Riluzole
  • Edaravone
  • 奇拉塞米替布
  • Nuedexta
  • 马赛替尼
  • 其他的

9. 肌萎缩侧索硬化症市场（依服务）

  • 市场概况
  • 病人支援服务
  • 咨询服务
  • 临床试验服务
  • 其他的

10. 肌萎缩侧索硬化症市场（按技术）

  • 市场概况
  • 生物技术
  • 药物基因体学
  • 基因治疗
  • 干细胞疗法
  • 其他的

11. 肌萎缩侧索硬化症市场（依成分）

  • 市场概况
  • 原料药
  • 辅料
  • 其他的

第 12 章肌萎缩侧索硬化症市场（按应用）

  • 市场概况
  • 医院
  • 门诊手术中心
  • 研究所
  • 其他的

13. 肌萎缩侧索硬化症市场（按设备）

  • 市场概况
  • 非侵入性通气
  • 经皮视镜胃造口术
  • 其他的

第 14 章。肌萎缩侧索硬化症市场（按过程）

  • 市场概况
  • 药物开发
  • 临床试验
  • 药品核准
  • 商业化
  • 其他的

第 15 章。肌萎缩侧索硬化症市场（依最终用户）

  • 市场概况
  • 医疗保健提供者
  • 病人
  • 製药公司
  • 其他的

16. 肌萎缩侧索硬化症市场（按地区）

  • 概述
  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
    • 瑞典
    • 瑞士
    • 丹麦
    • 芬兰
    • 俄罗斯
    • 其他欧洲国家
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 新加坡
    • 印尼
    • 台湾
    • 马来西亚
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 其他中东和非洲地区

第十七章竞争格局

  • 概述
  • 市占率分析
  • 主要企业定位
  • 衝突领导地图
  • 供应商基准化分析
  • 发展策略基准化分析

第十八章：公司简介

  • BrainStorm Cell Therapeutics
  • Mitsubishi Tanabe Pharma Corporation
  • Orphazyme
  • AB Science
  • MediciNova
  • Biogen
  • Ionis Pharmaceuticals
  • Cytokinetics
  • Amylyx Pharmaceuticals
  • Apellis Pharmaceuticals
  • Anelixis Therapeutics
  • Treeway
  • Genervon Biopharmaceuticals
  • NeuroSense Therapeutics
  • QurAlis
简介目录
Product Code: GIS33612

Amyotrophic Lateral Sclerosis Market is anticipated to expand from $1.2 billion in 2024 to $2.1 billion by 2034, growing at a CAGR of approximately 5.8%. The Amyotrophic Lateral Sclerosis (ALS) Market encompasses pharmaceuticals, diagnostics, and supportive care aimed at managing ALS, a progressive neurodegenerative disorder. The market is driven by advancements in gene therapy, novel drug development, and increased research funding. Rising awareness and improved diagnostic techniques are propelling demand for innovative treatments. Strategic collaborations and regulatory support further enhance market growth, focusing on extending patient lifespans and improving quality of life.

The Amyotrophic Lateral Sclerosis (ALS) Market is experiencing dynamic growth, propelled by advancements in therapeutic options and diagnostic innovations. The therapeutics segment is the top performer, with disease-modifying therapies and symptomatic treatments leading the charge. Innovative drug formulations and novel therapeutic classes are driving this segment's expansion. The diagnostics segment follows as the second highest performer, with significant advancements in biomarker technologies and genetic testing. These innovations are enhancing early diagnosis and personalized treatment approaches. Research and development activities are intensifying, focusing on neuroprotective agents and regenerative medicine. Emerging biotechnologies and gene therapies are capturing attention, promising to revolutionize ALS treatment paradigms. The integration of artificial intelligence in drug discovery and patient management is further augmenting growth prospects. Collaborations between pharmaceutical companies and research institutions are fostering innovation, accelerating the development of effective solutions. The increasing awareness and advocacy for ALS are also contributing to heightened demand for advanced healthcare solutions.

Market Segmentation
TypeSporadic ALS, Familial ALS
ProductRiluzole, Edaravone, Tirasemtiv, Nuedexta, Masitinib
ServicesPatient Support Services, Consultation Services, Clinical Trial Services
TechnologyBiotechnology, Pharmacogenomics, Gene Therapy, Stem Cell Therapy
ComponentActive Pharmaceutical Ingredients, Excipients
ApplicationHospitals, Ambulatory Surgical Centers, Research Institutes
DeviceNon-Invasive Ventilation, Percutaneous Endoscopic Gastrostomy
ProcessDrug Development, Clinical Trials, Regulatory Approval, Commercialization
End UserHealthcare Providers, Patients, Pharmaceutical Companies

Market Snapshot:

The Amyotrophic Lateral Sclerosis (ALS) market is witnessing dynamic shifts with significant market share held by leading pharmaceutical companies. Pricing strategies are evolving in response to competitive pressures and patient needs, with innovative pricing models emerging. New product launches are invigorating the market, driven by advancements in biotechnology and a deeper understanding of disease mechanisms. These developments are enhancing treatment options and improving patient outcomes, fostering a competitive landscape. Competition benchmarking reveals a robust rivalry among key players, with strategic partnerships and collaborations shaping the market dynamics. Regulatory influences are pivotal, as agencies in North America and Europe impose stringent guidelines, impacting market entry and expansion strategies. The ALS market is characterized by high R&D investments, focusing on novel therapeutics and personalized medicine. The landscape is further complicated by patent expirations and generic drug entries, which are expected to alter the competitive equilibrium and drive market evolution.

Geographical Overview:

The Amyotrophic Lateral Sclerosis (ALS) market is witnessing varied growth patterns across different regions. North America remains at the forefront, driven by advanced healthcare infrastructure and significant research investments. The presence of leading pharmaceutical companies and robust funding for ALS research further bolster market expansion. Europe follows, with increased awareness and government initiatives supporting ALS treatment advancements. Asia Pacific is emerging as a promising growth pocket, propelled by rising healthcare expenditure and expanding patient awareness. Countries like China and Japan are at the helm, investing heavily in research and development. Meanwhile, Latin America and the Middle East & Africa are gradually gaining momentum. These regions are recognizing the need for improved healthcare frameworks and are beginning to channel resources towards ALS treatment and research. Brazil and South Africa are notable emerging players, showing potential for substantial market growth in the coming years.

Key Trends and Drivers:

The Amyotrophic Lateral Sclerosis (ALS) market is evolving, driven by advancements in research and therapeutic development. Increased funding for neurological research is propelling the discovery of innovative treatment modalities. New drug approvals and clinical trials are expanding therapeutic options, addressing unmet medical needs in ALS care. The rise of personalized medicine is a key trend, with genetic testing enabling targeted therapies tailored to individual patient profiles. This approach enhances treatment efficacy and patient outcomes. Collaborations between pharmaceutical companies and research institutions are accelerating the pace of innovation. Digital health technologies, including telemedicine and remote monitoring, are transforming patient management, improving accessibility to care. These technologies facilitate real-time data collection, enhancing disease tracking and intervention strategies. Regulatory support and incentives for orphan drug development are fostering a conducive environment for market growth. The ALS market is poised for expansion as stakeholders capitalize on these trends, driving progress in diagnosis, treatment, and patient care.

Restraints and Challenges:

The Amyotrophic Lateral Sclerosis (ALS) market encounters several substantial restraints and challenges. A significant restraint is the high cost of drug development and clinical trials. This financial burden limits the entry of new players and slows the pace of innovation. Additionally, the rarity of ALS results in a limited patient pool for clinical studies, which complicates the recruitment process and extends timelines. Another challenge is the lack of definitive diagnostic tests. This results in delayed diagnosis and treatment initiation, affecting patient outcomes. The complexity of ALS pathology also hinders the development of effective therapies. Researchers face difficulties in understanding the disease's underlying mechanisms. Furthermore, regulatory hurdles and stringent approval processes for new treatments can delay market entry. There is also a significant need for increased awareness and education among healthcare professionals and the public. This gap in knowledge can impede early diagnosis and intervention, affecting overall market growth.

Key Players:

BrainStorm Cell Therapeutics, Mitsubishi Tanabe Pharma Corporation, Orphazyme, AB Science, MediciNova, Biogen, Ionis Pharmaceuticals, Cytokinetics, Amylyx Pharmaceuticals, Apellis Pharmaceuticals, Anelixis Therapeutics, Treeway, Genervon Biopharmaceuticals, NeuroSense Therapeutics, QurAlis

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: Amyotrophic Lateral Sclerosis Market Overview

  • 1.1 Objectives of the Study
  • 1.2 Amyotrophic Lateral Sclerosis Market Definition and Scope of the Report
  • 1.3 Report Limitations
  • 1.4 Years & Currency Considered in the Study
  • 1.5 Research Methodologies
    • 1.5.1 Secondary Research
    • 1.5.2 Primary Research
    • 1.5.3 Market Size Estimation: Top-Down Approach
    • 1.5.4 Market Size Estimation: Bottom-Up Approach
    • 1.5.5 Data Triangulation and Validation

2: Executive Summary

  • 2.1 Summary
  • 2.2 Key Opinion Leaders
  • 2.3 Key Highlights of the Market, by Type
  • 2.4 Key Highlights of the Market, by Product
  • 2.5 Key Highlights of the Market, by Services
  • 2.6 Key Highlights of the Market, by Technology
  • 2.7 Key Highlights of the Market, by Component
  • 2.8 Key Highlights of the Market, by Application
  • 2.9 Key Highlights of the Market, by Device
  • 2.10 Key Highlights of the Market, by Process
  • 2.11 Key Highlights of the Market, by End User
  • 2.12 Key Highlights of the Market, by North America
  • 2.13 Key Highlights of the Market, by Europe
  • 2.14 Key Highlights of the Market, by Asia-Pacific
  • 2.15 Key Highlights of the Market, by Latin America
  • 2.16 Key Highlights of the Market, by Middle East
  • 2.17 Key Highlights of the Market, by Africa

3: Premium Insights on the Market

  • 3.1 Market Attractiveness Analysis, by Region
  • 3.2 Market Attractiveness Analysis, by Type
  • 3.3 Market Attractiveness Analysis, by Product
  • 3.4 Market Attractiveness Analysis, by Services
  • 3.5 Market Attractiveness Analysis, by Technology
  • 3.6 Market Attractiveness Analysis, by Component
  • 3.7 Market Attractiveness Analysis, by Application
  • 3.8 Market Attractiveness Analysis, by Device
  • 3.9 Market Attractiveness Analysis, by Process
  • 3.10 Market Attractiveness Analysis, by End User
  • 3.11 Market Attractiveness Analysis, by North America
  • 3.12 Market Attractiveness Analysis, by Europe
  • 3.13 Market Attractiveness Analysis, by Asia-Pacific
  • 3.14 Market Attractiveness Analysis, by Latin America
  • 3.15 Market Attractiveness Analysis, by Middle East
  • 3.16 Market Attractiveness Analysis, by Africa

4: Amyotrophic Lateral Sclerosis Market Outlook

  • 4.1 Amyotrophic Lateral Sclerosis Market Segmentation
  • 4.2 Market Dynamics
    • 4.2.1 Market Drivers
    • 4.2.2 Market Trends
    • 4.2.3 Market Restraints
    • 4.2.4 Market Opportunities
  • 4.3 Porters Five Forces Analysis
    • 4.3.1 Threat of New Entrants
    • 4.3.2 Threat of Substitutes
    • 4.3.3 Bargaining Power of Buyers
    • 4.3.4 Bargaining Power of Supplier
    • 4.3.5 Competitive Rivalry
  • 4.4 PESTLE Analysis
  • 4.5 Value Chain Analysis
  • 4.6 4Ps Model
  • 4.7 ANSOFF Matrix

5: Amyotrophic Lateral Sclerosis Market Strategy

  • 5.1 Parent Market Analysis
  • 5.2 Supply-Demand Analysis
  • 5.3 Consumer Buying Interest
  • 5.4 Case Study Analysis
  • 5.5 Pricing Analysis
  • 5.6 Regulatory Landscape
  • 5.7 Supply Chain Analysis
  • 5.8 Competition Product Analysis
  • 5.9 Recent Developments

6: Amyotrophic Lateral Sclerosis Market Size

  • 6.1 Amyotrophic Lateral Sclerosis Market Size, by Value
  • 6.2 Amyotrophic Lateral Sclerosis Market Size, by Volume

7: Amyotrophic Lateral Sclerosis Market, by Type

  • 7.1 Market Overview
  • 7.2 Sporadic ALS
    • 7.2.1 Key Market Trends & Opportunity Analysis
    • 7.2.2 Market Size and Forecast, by Region
  • 7.3 Familial ALS
    • 7.3.1 Key Market Trends & Opportunity Analysis
    • 7.3.2 Market Size and Forecast, by Region
  • 7.4 Others
    • 7.4.1 Key Market Trends & Opportunity Analysis
    • 7.4.2 Market Size and Forecast, by Region

8: Amyotrophic Lateral Sclerosis Market, by Product

  • 8.1 Market Overview
  • 8.2 Riluzole
    • 8.2.1 Key Market Trends & Opportunity Analysis
    • 8.2.2 Market Size and Forecast, by Region
  • 8.3 Edaravone
    • 8.3.1 Key Market Trends & Opportunity Analysis
    • 8.3.2 Market Size and Forecast, by Region
  • 8.4 Tirasemtiv
    • 8.4.1 Key Market Trends & Opportunity Analysis
    • 8.4.2 Market Size and Forecast, by Region
  • 8.5 Nuedexta
    • 8.5.1 Key Market Trends & Opportunity Analysis
    • 8.5.2 Market Size and Forecast, by Region
  • 8.6 Masitinib
    • 8.6.1 Key Market Trends & Opportunity Analysis
    • 8.6.2 Market Size and Forecast, by Region
  • 8.7 Others
    • 8.7.1 Key Market Trends & Opportunity Analysis
    • 8.7.2 Market Size and Forecast, by Region

9: Amyotrophic Lateral Sclerosis Market, by Services

  • 9.1 Market Overview
  • 9.2 Patient Support Services
    • 9.2.1 Key Market Trends & Opportunity Analysis
    • 9.2.2 Market Size and Forecast, by Region
  • 9.3 Consultation Services
    • 9.3.1 Key Market Trends & Opportunity Analysis
    • 9.3.2 Market Size and Forecast, by Region
  • 9.4 Clinical Trial Services
    • 9.4.1 Key Market Trends & Opportunity Analysis
    • 9.4.2 Market Size and Forecast, by Region
  • 9.5 Others
    • 9.5.1 Key Market Trends & Opportunity Analysis
    • 9.5.2 Market Size and Forecast, by Region

10: Amyotrophic Lateral Sclerosis Market, by Technology

  • 10.1 Market Overview
  • 10.2 Biotechnology
    • 10.2.1 Key Market Trends & Opportunity Analysis
    • 10.2.2 Market Size and Forecast, by Region
  • 10.3 Pharmacogenomics
    • 10.3.1 Key Market Trends & Opportunity Analysis
    • 10.3.2 Market Size and Forecast, by Region
  • 10.4 Gene Therapy
    • 10.4.1 Key Market Trends & Opportunity Analysis
    • 10.4.2 Market Size and Forecast, by Region
  • 10.5 Stem Cell Therapy
    • 10.5.1 Key Market Trends & Opportunity Analysis
    • 10.5.2 Market Size and Forecast, by Region
  • 10.6 Others
    • 10.6.1 Key Market Trends & Opportunity Analysis
    • 10.6.2 Market Size and Forecast, by Region

11: Amyotrophic Lateral Sclerosis Market, by Component

  • 11.1 Market Overview
  • 11.2 Active Pharmaceutical Ingredients
    • 11.2.1 Key Market Trends & Opportunity Analysis
    • 11.2.2 Market Size and Forecast, by Region
  • 11.3 Excipients
    • 11.3.1 Key Market Trends & Opportunity Analysis
    • 11.3.2 Market Size and Forecast, by Region
  • 11.4 Others
    • 11.4.1 Key Market Trends & Opportunity Analysis
    • 11.4.2 Market Size and Forecast, by Region

12: Amyotrophic Lateral Sclerosis Market, by Application

  • 12.1 Market Overview
  • 12.2 Hospitals
    • 12.2.1 Key Market Trends & Opportunity Analysis
    • 12.2.2 Market Size and Forecast, by Region
  • 12.3 Ambulatory Surgical Centers
    • 12.3.1 Key Market Trends & Opportunity Analysis
    • 12.3.2 Market Size and Forecast, by Region
  • 12.4 Research Institutes
    • 12.4.1 Key Market Trends & Opportunity Analysis
    • 12.4.2 Market Size and Forecast, by Region
  • 12.5 Others
    • 12.5.1 Key Market Trends & Opportunity Analysis
    • 12.5.2 Market Size and Forecast, by Region

13: Amyotrophic Lateral Sclerosis Market, by Device

  • 13.1 Market Overview
  • 13.2 Non-Invasive Ventilation
    • 13.2.1 Key Market Trends & Opportunity Analysis
    • 13.2.2 Market Size and Forecast, by Region
  • 13.3 Percutaneous Endoscopic Gastrostomy
    • 13.3.1 Key Market Trends & Opportunity Analysis
    • 13.3.2 Market Size and Forecast, by Region
  • 13.4 Others
    • 13.4.1 Key Market Trends & Opportunity Analysis
    • 13.4.2 Market Size and Forecast, by Region

14: Amyotrophic Lateral Sclerosis Market, by Process

  • 14.1 Market Overview
  • 14.2 Drug Development
    • 14.2.1 Key Market Trends & Opportunity Analysis
    • 14.2.2 Market Size and Forecast, by Region
  • 14.3 Clinical Trials
    • 14.3.1 Key Market Trends & Opportunity Analysis
    • 14.3.2 Market Size and Forecast, by Region
  • 14.4 Regulatory Approval
    • 14.4.1 Key Market Trends & Opportunity Analysis
    • 14.4.2 Market Size and Forecast, by Region
  • 14.5 Commercialization
    • 14.5.1 Key Market Trends & Opportunity Analysis
    • 14.5.2 Market Size and Forecast, by Region
  • 14.6 Others
    • 14.6.1 Key Market Trends & Opportunity Analysis
    • 14.6.2 Market Size and Forecast, by Region

15: Amyotrophic Lateral Sclerosis Market, by End User

  • 15.1 Market Overview
  • 15.2 Healthcare Providers
    • 15.2.1 Key Market Trends & Opportunity Analysis
    • 15.2.2 Market Size and Forecast, by Region
  • 15.3 Patients
    • 15.3.1 Key Market Trends & Opportunity Analysis
    • 15.3.2 Market Size and Forecast, by Region
  • 15.4 Pharmaceutical Companies
    • 15.4.1 Key Market Trends & Opportunity Analysis
    • 15.4.2 Market Size and Forecast, by Region
  • 15.5 Others
    • 15.5.1 Key Market Trends & Opportunity Analysis
    • 15.5.2 Market Size and Forecast, by Region

16: Amyotrophic Lateral Sclerosis Market, by Region

  • 16.1 Overview
  • 16.2 North America
    • 16.2.1 Key Market Trends and Opportunities
    • 16.2.2 North America Market Size and Forecast, by Type
    • 16.2.3 North America Market Size and Forecast, by Product
    • 16.2.4 North America Market Size and Forecast, by Services
    • 16.2.5 North America Market Size and Forecast, by Technology
    • 16.2.6 North America Market Size and Forecast, by Component
    • 16.2.7 North America Market Size and Forecast, by Application
    • 16.2.8 North America Market Size and Forecast, by Device
    • 16.2.9 North America Market Size and Forecast, by Process
    • 16.2.10 North America Market Size and Forecast, by End User
    • 16.2.11 North America Market Size and Forecast, by Country
    • 16.2.12 United States
      • 16.2.9.1 United States Market Size and Forecast, by Type
      • 16.2.9.2 United States Market Size and Forecast, by Product
      • 16.2.9.3 United States Market Size and Forecast, by Services
      • 16.2.9.4 United States Market Size and Forecast, by Technology
      • 16.2.9.5 United States Market Size and Forecast, by Component
      • 16.2.9.6 United States Market Size and Forecast, by Application
      • 16.2.9.7 United States Market Size and Forecast, by Device
      • 16.2.9.8 United States Market Size and Forecast, by Process
      • 16.2.9.9 United States Market Size and Forecast, by End User
      • 16.2.9.10 Local Competition Analysis
      • 16.2.9.11 Local Market Analysis
    • 16.2.1 Canada
      • 16.2.10.1 Canada Market Size and Forecast, by Type
      • 16.2.10.2 Canada Market Size and Forecast, by Product
      • 16.2.10.3 Canada Market Size and Forecast, by Services
      • 16.2.10.4 Canada Market Size and Forecast, by Technology
      • 16.2.10.5 Canada Market Size and Forecast, by Component
      • 16.2.10.6 Canada Market Size and Forecast, by Application
      • 16.2.10.7 Canada Market Size and Forecast, by Device
      • 16.2.10.8 Canada Market Size and Forecast, by Process
      • 16.2.10.9 Canada Market Size and Forecast, by End User
      • 16.2.10.10 Local Competition Analysis
      • 16.2.10.11 Local Market Analysis
  • 16.1 Europe
    • 16.3.1 Key Market Trends and Opportunities
    • 16.3.2 Europe Market Size and Forecast, by Type
    • 16.3.3 Europe Market Size and Forecast, by Product
    • 16.3.4 Europe Market Size and Forecast, by Services
    • 16.3.5 Europe Market Size and Forecast, by Technology
    • 16.3.6 Europe Market Size and Forecast, by Component
    • 16.3.7 Europe Market Size and Forecast, by Application
    • 16.3.8 Europe Market Size and Forecast, by Device
    • 16.3.9 Europe Market Size and Forecast, by Process
    • 16.3.10 Europe Market Size and Forecast, by End User
    • 16.3.11 Europe Market Size and Forecast, by Country
    • 16.3.12 United Kingdom
      • 16.3.9.1 United Kingdom Market Size and Forecast, by Type
      • 16.3.9.2 United Kingdom Market Size and Forecast, by Product
      • 16.3.9.3 United Kingdom Market Size and Forecast, by Services
      • 16.3.9.4 United Kingdom Market Size and Forecast, by Technology
      • 16.3.9.5 United Kingdom Market Size and Forecast, by Component
      • 16.3.9.6 United Kingdom Market Size and Forecast, by Application
      • 16.3.9.7 United Kingdom Market Size and Forecast, by Device
      • 16.3.9.8 United Kingdom Market Size and Forecast, by Process
      • 16.3.9.9 United Kingdom Market Size and Forecast, by End User
      • 16.3.9.10 Local Competition Analysis
      • 16.3.9.11 Local Market Analysis
    • 16.3.1 Germany
      • 16.3.10.1 Germany Market Size and Forecast, by Type
      • 16.3.10.2 Germany Market Size and Forecast, by Product
      • 16.3.10.3 Germany Market Size and Forecast, by Services
      • 16.3.10.4 Germany Market Size and Forecast, by Technology
      • 16.3.10.5 Germany Market Size and Forecast, by Component
      • 16.3.10.6 Germany Market Size and Forecast, by Application
      • 16.3.10.7 Germany Market Size and Forecast, by Device
      • 16.3.10.8 Germany Market Size and Forecast, by Process
      • 16.3.10.9 Germany Market Size and Forecast, by End User
      • 16.3.10.10 Local Competition Analysis
      • 16.3.10.11 Local Market Analysis
    • 16.3.1 France
      • 16.3.11.1 France Market Size and Forecast, by Type
      • 16.3.11.2 France Market Size and Forecast, by Product
      • 16.3.11.3 France Market Size and Forecast, by Services
      • 16.3.11.4 France Market Size and Forecast, by Technology
      • 16.3.11.5 France Market Size and Forecast, by Component
      • 16.3.11.6 France Market Size and Forecast, by Application
      • 16.3.11.7 France Market Size and Forecast, by Device
      • 16.3.11.8 France Market Size and Forecast, by Process
      • 16.3.11.9 France Market Size and Forecast, by End User
      • 16.3.11.10 Local Competition Analysis
      • 16.3.11.11 Local Market Analysis
    • 16.3.1 Spain
      • 16.3.12.1 Spain Market Size and Forecast, by Type
      • 16.3.12.2 Spain Market Size and Forecast, by Product
      • 16.3.12.3 Spain Market Size and Forecast, by Services
      • 16.3.12.4 Spain Market Size and Forecast, by Technology
      • 16.3.12.5 Spain Market Size and Forecast, by Component
      • 16.3.12.6 Spain Market Size and Forecast, by Application
      • 16.3.12.7 Spain Market Size and Forecast, by Device
      • 16.3.12.8 Spain Market Size and Forecast, by Process
      • 16.3.12.9 Spain Market Size and Forecast, by End User
      • 16.3.12.10 Local Competition Analysis
      • 16.3.12.11 Local Market Analysis
    • 16.3.1 Italy
      • 16.3.13.1 Italy Market Size and Forecast, by Type
      • 16.3.13.2 Italy Market Size and Forecast, by Product
      • 16.3.13.3 Italy Market Size and Forecast, by Services
      • 16.3.13.4 Italy Market Size and Forecast, by Technology
      • 16.3.13.5 Italy Market Size and Forecast, by Component
      • 16.3.13.6 Italy Market Size and Forecast, by Application
      • 16.3.13.7 Italy Market Size and Forecast, by Device
      • 16.3.13.8 Italy Market Size and Forecast, by Process
      • 16.3.13.9 Italy Market Size and Forecast, by End User
      • 16.3.13.10 Local Competition Analysis
      • 16.3.13.11 Local Market Analysis
    • 16.3.1 Netherlands
      • 16.3.14.1 Netherlands Market Size and Forecast, by Type
      • 16.3.14.2 Netherlands Market Size and Forecast, by Product
      • 16.3.14.3 Netherlands Market Size and Forecast, by Services
      • 16.3.14.4 Netherlands Market Size and Forecast, by Technology
      • 16.3.14.5 Netherlands Market Size and Forecast, by Component
      • 16.3.14.6 Netherlands Market Size and Forecast, by Application
      • 16.3.14.7 Netherlands Market Size and Forecast, by Device
      • 16.3.14.8 Netherlands Market Size and Forecast, by Process
      • 16.3.14.9 Netherlands Market Size and Forecast, by End User
      • 16.3.14.10 Local Competition Analysis
      • 16.3.14.11 Local Market Analysis
    • 16.3.1 Sweden
      • 16.3.15.1 Sweden Market Size and Forecast, by Type
      • 16.3.15.2 Sweden Market Size and Forecast, by Product
      • 16.3.15.3 Sweden Market Size and Forecast, by Services
      • 16.3.15.4 Sweden Market Size and Forecast, by Technology
      • 16.3.15.5 Sweden Market Size and Forecast, by Component
      • 16.3.15.6 Sweden Market Size and Forecast, by Application
      • 16.3.15.7 Sweden Market Size and Forecast, by Device
      • 16.3.15.8 Sweden Market Size and Forecast, by Process
      • 16.3.15.9 Sweden Market Size and Forecast, by End User
      • 16.3.15.10 Local Competition Analysis
      • 16.3.15.11 Local Market Analysis
    • 16.3.1 Switzerland
      • 16.3.16.1 Switzerland Market Size and Forecast, by Type
      • 16.3.16.2 Switzerland Market Size and Forecast, by Product
      • 16.3.16.3 Switzerland Market Size and Forecast, by Services
      • 16.3.16.4 Switzerland Market Size and Forecast, by Technology
      • 16.3.16.5 Switzerland Market Size and Forecast, by Component
      • 16.3.16.6 Switzerland Market Size and Forecast, by Application
      • 16.3.16.7 Switzerland Market Size and Forecast, by Device
      • 16.3.16.8 Switzerland Market Size and Forecast, by Process
      • 16.3.16.9 Switzerland Market Size and Forecast, by End User
      • 16.3.16.10 Local Competition Analysis
      • 16.3.16.11 Local Market Analysis
    • 16.3.1 Denmark
      • 16.3.17.1 Denmark Market Size and Forecast, by Type
      • 16.3.17.2 Denmark Market Size and Forecast, by Product
      • 16.3.17.3 Denmark Market Size and Forecast, by Services
      • 16.3.17.4 Denmark Market Size and Forecast, by Technology
      • 16.3.17.5 Denmark Market Size and Forecast, by Component
      • 16.3.17.6 Denmark Market Size and Forecast, by Application
      • 16.3.17.7 Denmark Market Size and Forecast, by Device
      • 16.3.17.8 Denmark Market Size and Forecast, by Process
      • 16.3.17.9 Denmark Market Size and Forecast, by End User
      • 16.3.17.10 Local Competition Analysis
      • 16.3.17.11 Local Market Analysis
    • 16.3.1 Finland
      • 16.3.18.1 Finland Market Size and Forecast, by Type
      • 16.3.18.2 Finland Market Size and Forecast, by Product
      • 16.3.18.3 Finland Market Size and Forecast, by Services
      • 16.3.18.4 Finland Market Size and Forecast, by Technology
      • 16.3.18.5 Finland Market Size and Forecast, by Component
      • 16.3.18.6 Finland Market Size and Forecast, by Application
      • 16.3.18.7 Finland Market Size and Forecast, by Device
      • 16.3.18.8 Finland Market Size and Forecast, by Process
      • 16.3.18.9 Finland Market Size and Forecast, by End User
      • 16.3.18.10 Local Competition Analysis
      • 16.3.18.11 Local Market Analysis
    • 16.3.1 Russia
      • 16.3.19.1 Russia Market Size and Forecast, by Type
      • 16.3.19.2 Russia Market Size and Forecast, by Product
      • 16.3.19.3 Russia Market Size and Forecast, by Services
      • 16.3.19.4 Russia Market Size and Forecast, by Technology
      • 16.3.19.5 Russia Market Size and Forecast, by Component
      • 16.3.19.6 Russia Market Size and Forecast, by Application
      • 16.3.19.7 Russia Market Size and Forecast, by Device
      • 16.3.19.8 Russia Market Size and Forecast, by Process
      • 16.3.19.9 Russia Market Size and Forecast, by End User
      • 16.3.19.10 Local Competition Analysis
      • 16.3.19.11 Local Market Analysis
    • 16.3.1 Rest of Europe
      • 16.3.20.1 Rest of Europe Market Size and Forecast, by Type
      • 16.3.20.2 Rest of Europe Market Size and Forecast, by Product
      • 16.3.20.3 Rest of Europe Market Size and Forecast, by Services
      • 16.3.20.4 Rest of Europe Market Size and Forecast, by Technology
      • 16.3.20.5 Rest of Europe Market Size and Forecast, by Component
      • 16.3.20.6 Rest of Europe Market Size and Forecast, by Application
      • 16.3.20.7 Rest of Europe Market Size and Forecast, by Device
      • 16.3.20.8 Rest of Europe Market Size and Forecast, by Process
      • 16.3.20.9 Rest of Europe Market Size and Forecast, by End User
      • 16.3.20.10 Local Competition Analysis
      • 16.3.20.11 Local Market Analysis
  • 16.1 Asia-Pacific
    • 16.4.1 Key Market Trends and Opportunities
    • 16.4.2 Asia-Pacific Market Size and Forecast, by Type
    • 16.4.3 Asia-Pacific Market Size and Forecast, by Product
    • 16.4.4 Asia-Pacific Market Size and Forecast, by Services
    • 16.4.5 Asia-Pacific Market Size and Forecast, by Technology
    • 16.4.6 Asia-Pacific Market Size and Forecast, by Component
    • 16.4.7 Asia-Pacific Market Size and Forecast, by Application
    • 16.4.8 Asia-Pacific Market Size and Forecast, by Device
    • 16.4.9 Asia-Pacific Market Size and Forecast, by Process
    • 16.4.10 Asia-Pacific Market Size and Forecast, by End User
    • 16.4.11 Asia-Pacific Market Size and Forecast, by Country
    • 16.4.12 China
      • 16.4.9.1 China Market Size and Forecast, by Type
      • 16.4.9.2 China Market Size and Forecast, by Product
      • 16.4.9.3 China Market Size and Forecast, by Services
      • 16.4.9.4 China Market Size and Forecast, by Technology
      • 16.4.9.5 China Market Size and Forecast, by Component
      • 16.4.9.6 China Market Size and Forecast, by Application
      • 16.4.9.7 China Market Size and Forecast, by Device
      • 16.4.9.8 China Market Size and Forecast, by Process
      • 16.4.9.9 China Market Size and Forecast, by End User
      • 16.4.9.10 Local Competition Analysis
      • 16.4.9.11 Local Market Analysis
    • 16.4.1 India
      • 16.4.10.1 India Market Size and Forecast, by Type
      • 16.4.10.2 India Market Size and Forecast, by Product
      • 16.4.10.3 India Market Size and Forecast, by Services
      • 16.4.10.4 India Market Size and Forecast, by Technology
      • 16.4.10.5 India Market Size and Forecast, by Component
      • 16.4.10.6 India Market Size and Forecast, by Application
      • 16.4.10.7 India Market Size and Forecast, by Device
      • 16.4.10.8 India Market Size and Forecast, by Process
      • 16.4.10.9 India Market Size and Forecast, by End User
      • 16.4.10.10 Local Competition Analysis
      • 16.4.10.11 Local Market Analysis
    • 16.4.1 Japan
      • 16.4.11.1 Japan Market Size and Forecast, by Type
      • 16.4.11.2 Japan Market Size and Forecast, by Product
      • 16.4.11.3 Japan Market Size and Forecast, by Services
      • 16.4.11.4 Japan Market Size and Forecast, by Technology
      • 16.4.11.5 Japan Market Size and Forecast, by Component
      • 16.4.11.6 Japan Market Size and Forecast, by Application
      • 16.4.11.7 Japan Market Size and Forecast, by Device
      • 16.4.11.8 Japan Market Size and Forecast, by Process
      • 16.4.11.9 Japan Market Size and Forecast, by End User
      • 16.4.11.10 Local Competition Analysis
      • 16.4.11.11 Local Market Analysis
    • 16.4.1 South Korea
      • 16.4.12.1 South Korea Market Size and Forecast, by Type
      • 16.4.12.2 South Korea Market Size and Forecast, by Product
      • 16.4.12.3 South Korea Market Size and Forecast, by Services
      • 16.4.12.4 South Korea Market Size and Forecast, by Technology
      • 16.4.12.5 South Korea Market Size and Forecast, by Component
      • 16.4.12.6 South Korea Market Size and Forecast, by Application
      • 16.4.12.7 South Korea Market Size and Forecast, by Device
      • 16.4.12.8 South Korea Market Size and Forecast, by Process
      • 16.4.12.9 South Korea Market Size and Forecast, by End User
      • 16.4.12.10 Local Competition Analysis
      • 16.4.12.11 Local Market Analysis
    • 16.4.1 Australia
      • 16.4.13.1 Australia Market Size and Forecast, by Type
      • 16.4.13.2 Australia Market Size and Forecast, by Product
      • 16.4.13.3 Australia Market Size and Forecast, by Services
      • 16.4.13.4 Australia Market Size and Forecast, by Technology
      • 16.4.13.5 Australia Market Size and Forecast, by Component
      • 16.4.13.6 Australia Market Size and Forecast, by Application
      • 16.4.13.7 Australia Market Size and Forecast, by Device
      • 16.4.13.8 Australia Market Size and Forecast, by Process
      • 16.4.13.9 Australia Market Size and Forecast, by End User
      • 16.4.13.10 Local Competition Analysis
      • 16.4.13.11 Local Market Analysis
    • 16.4.1 Singapore
      • 16.4.14.1 Singapore Market Size and Forecast, by Type
      • 16.4.14.2 Singapore Market Size and Forecast, by Product
      • 16.4.14.3 Singapore Market Size and Forecast, by Services
      • 16.4.14.4 Singapore Market Size and Forecast, by Technology
      • 16.4.14.5 Singapore Market Size and Forecast, by Component
      • 16.4.14.6 Singapore Market Size and Forecast, by Application
      • 16.4.14.7 Singapore Market Size and Forecast, by Device
      • 16.4.14.8 Singapore Market Size and Forecast, by Process
      • 16.4.14.9 Singapore Market Size and Forecast, by End User
      • 16.4.14.10 Local Competition Analysis
      • 16.4.14.11 Local Market Analysis
    • 16.4.1 Indonesia
      • 16.4.15.1 Indonesia Market Size and Forecast, by Type
      • 16.4.15.2 Indonesia Market Size and Forecast, by Product
      • 16.4.15.3 Indonesia Market Size and Forecast, by Services
      • 16.4.15.4 Indonesia Market Size and Forecast, by Technology
      • 16.4.15.5 Indonesia Market Size and Forecast, by Component
      • 16.4.15.6 Indonesia Market Size and Forecast, by Application
      • 16.4.15.7 Indonesia Market Size and Forecast, by Device
      • 16.4.15.8 Indonesia Market Size and Forecast, by Process
      • 16.4.15.9 Indonesia Market Size and Forecast, by End User
      • 16.4.15.10 Local Competition Analysis
      • 16.4.15.11 Local Market Analysis
    • 16.4.1 Taiwan
      • 16.4.16.1 Taiwan Market Size and Forecast, by Type
      • 16.4.16.2 Taiwan Market Size and Forecast, by Product
      • 16.4.16.3 Taiwan Market Size and Forecast, by Services
      • 16.4.16.4 Taiwan Market Size and Forecast, by Technology
      • 16.4.16.5 Taiwan Market Size and Forecast, by Component
      • 16.4.16.6 Taiwan Market Size and Forecast, by Application
      • 16.4.16.7 Taiwan Market Size and Forecast, by Device
      • 16.4.16.8 Taiwan Market Size and Forecast, by Process
      • 16.4.16.9 Taiwan Market Size and Forecast, by End User
      • 16.4.16.10 Local Competition Analysis
      • 16.4.16.11 Local Market Analysis
    • 16.4.1 Malaysia
      • 16.4.17.1 Malaysia Market Size and Forecast, by Type
      • 16.4.17.2 Malaysia Market Size and Forecast, by Product
      • 16.4.17.3 Malaysia Market Size and Forecast, by Services
      • 16.4.17.4 Malaysia Market Size and Forecast, by Technology
      • 16.4.17.5 Malaysia Market Size and Forecast, by Component
      • 16.4.17.6 Malaysia Market Size and Forecast, by Application
      • 16.4.17.7 Malaysia Market Size and Forecast, by Device
      • 16.4.17.8 Malaysia Market Size and Forecast, by Process
      • 16.4.17.9 Malaysia Market Size and Forecast, by End User
      • 16.4.17.10 Local Competition Analysis
      • 16.4.17.11 Local Market Analysis
    • 16.4.1 Rest of Asia-Pacific
      • 16.4.18.1 Rest of Asia-Pacific Market Size and Forecast, by Type
      • 16.4.18.2 Rest of Asia-Pacific Market Size and Forecast, by Product
      • 16.4.18.3 Rest of Asia-Pacific Market Size and Forecast, by Services
      • 16.4.18.4 Rest of Asia-Pacific Market Size and Forecast, by Technology
      • 16.4.18.5 Rest of Asia-Pacific Market Size and Forecast, by Component
      • 16.4.18.6 Rest of Asia-Pacific Market Size and Forecast, by Application
      • 16.4.18.7 Rest of Asia-Pacific Market Size and Forecast, by Device
      • 16.4.18.8 Rest of Asia-Pacific Market Size and Forecast, by Process
      • 16.4.18.9 Rest of Asia-Pacific Market Size and Forecast, by End User
      • 16.4.18.10 Local Competition Analysis
      • 16.4.18.11 Local Market Analysis
  • 16.1 Latin America
    • 16.5.1 Key Market Trends and Opportunities
    • 16.5.2 Latin America Market Size and Forecast, by Type
    • 16.5.3 Latin America Market Size and Forecast, by Product
    • 16.5.4 Latin America Market Size and Forecast, by Services
    • 16.5.5 Latin America Market Size and Forecast, by Technology
    • 16.5.6 Latin America Market Size and Forecast, by Component
    • 16.5.7 Latin America Market Size and Forecast, by Application
    • 16.5.8 Latin America Market Size and Forecast, by Device
    • 16.5.9 Latin America Market Size and Forecast, by Process
    • 16.5.10 Latin America Market Size and Forecast, by End User
    • 16.5.11 Latin America Market Size and Forecast, by Country
    • 16.5.12 Brazil
      • 16.5.9.1 Brazil Market Size and Forecast, by Type
      • 16.5.9.2 Brazil Market Size and Forecast, by Product
      • 16.5.9.3 Brazil Market Size and Forecast, by Services
      • 16.5.9.4 Brazil Market Size and Forecast, by Technology
      • 16.5.9.5 Brazil Market Size and Forecast, by Component
      • 16.5.9.6 Brazil Market Size and Forecast, by Application
      • 16.5.9.7 Brazil Market Size and Forecast, by Device
      • 16.5.9.8 Brazil Market Size and Forecast, by Process
      • 16.5.9.9 Brazil Market Size and Forecast, by End User
      • 16.5.9.10 Local Competition Analysis
      • 16.5.9.11 Local Market Analysis
    • 16.5.1 Mexico
      • 16.5.10.1 Mexico Market Size and Forecast, by Type
      • 16.5.10.2 Mexico Market Size and Forecast, by Product
      • 16.5.10.3 Mexico Market Size and Forecast, by Services
      • 16.5.10.4 Mexico Market Size and Forecast, by Technology
      • 16.5.10.5 Mexico Market Size and Forecast, by Component
      • 16.5.10.6 Mexico Market Size and Forecast, by Application
      • 16.5.10.7 Mexico Market Size and Forecast, by Device
      • 16.5.10.8 Mexico Market Size and Forecast, by Process
      • 16.5.10.9 Mexico Market Size and Forecast, by End User
      • 16.5.10.10 Local Competition Analysis
      • 16.5.10.11 Local Market Analysis
    • 16.5.1 Argentina
      • 16.5.11.1 Argentina Market Size and Forecast, by Type
      • 16.5.11.2 Argentina Market Size and Forecast, by Product
      • 16.5.11.3 Argentina Market Size and Forecast, by Services
      • 16.5.11.4 Argentina Market Size and Forecast, by Technology
      • 16.5.11.5 Argentina Market Size and Forecast, by Component
      • 16.5.11.6 Argentina Market Size and Forecast, by Application
      • 16.5.11.7 Argentina Market Size and Forecast, by Device
      • 16.5.11.8 Argentina Market Size and Forecast, by Process
      • 16.5.11.9 Argentina Market Size and Forecast, by End User
      • 16.5.11.10 Local Competition Analysis
      • 16.5.11.11 Local Market Analysis
    • 16.5.1 Rest of Latin America
      • 16.5.12.1 Rest of Latin America Market Size and Forecast, by Type
      • 16.5.12.2 Rest of Latin America Market Size and Forecast, by Product
      • 16.5.12.3 Rest of Latin America Market Size and Forecast, by Services
      • 16.5.12.4 Rest of Latin America Market Size and Forecast, by Technology
      • 16.5.12.5 Rest of Latin America Market Size and Forecast, by Component
      • 16.5.12.6 Rest of Latin America Market Size and Forecast, by Application
      • 16.5.12.7 Rest of Latin America Market Size and Forecast, by Device
      • 16.5.12.8 Rest of Latin America Market Size and Forecast, by Process
      • 16.5.12.9 Rest of Latin America Market Size and Forecast, by End User
      • 16.5.12.10 Local Competition Analysis
      • 16.5.12.11 Local Market Analysis
  • 16.1 Middle East and Africa
    • 16.6.1 Key Market Trends and Opportunities
    • 16.6.2 Middle East and Africa Market Size and Forecast, by Type
    • 16.6.3 Middle East and Africa Market Size and Forecast, by Product
    • 16.6.4 Middle East and Africa Market Size and Forecast, by Services
    • 16.6.5 Middle East and Africa Market Size and Forecast, by Technology
    • 16.6.6 Middle East and Africa Market Size and Forecast, by Component
    • 16.6.7 Middle East and Africa Market Size and Forecast, by Application
    • 16.6.8 Middle East and Africa Market Size and Forecast, by Device
    • 16.6.9 Middle East and Africa Market Size and Forecast, by Process
    • 16.6.10 Middle East and Africa Market Size and Forecast, by End User
    • 16.6.11 Middle East and Africa Market Size and Forecast, by Country
    • 16.6.12 Saudi Arabia
      • 16.6.9.1 Saudi Arabia Market Size and Forecast, by Type
      • 16.6.9.2 Saudi Arabia Market Size and Forecast, by Product
      • 16.6.9.3 Saudi Arabia Market Size and Forecast, by Services
      • 16.6.9.4 Saudi Arabia Market Size and Forecast, by Technology
      • 16.6.9.5 Saudi Arabia Market Size and Forecast, by Component
      • 16.6.9.6 Saudi Arabia Market Size and Forecast, by Application
      • 16.6.9.7 Saudi Arabia Market Size and Forecast, by Device
      • 16.6.9.8 Saudi Arabia Market Size and Forecast, by Process
      • 16.6.9.9 Saudi Arabia Market Size and Forecast, by End User
      • 16.6.9.10 Local Competition Analysis
      • 16.6.9.11 Local Market Analysis
    • 16.6.1 UAE
      • 16.6.10.1 UAE Market Size and Forecast, by Type
      • 16.6.10.2 UAE Market Size and Forecast, by Product
      • 16.6.10.3 UAE Market Size and Forecast, by Services
      • 16.6.10.4 UAE Market Size and Forecast, by Technology
      • 16.6.10.5 UAE Market Size and Forecast, by Component
      • 16.6.10.6 UAE Market Size and Forecast, by Application
      • 16.6.10.7 UAE Market Size and Forecast, by Device
      • 16.6.10.8 UAE Market Size and Forecast, by Process
      • 16.6.10.9 UAE Market Size and Forecast, by End User
      • 16.6.10.10 Local Competition Analysis
      • 16.6.10.11 Local Market Analysis
    • 16.6.1 South Africa
      • 16.6.11.1 South Africa Market Size and Forecast, by Type
      • 16.6.11.2 South Africa Market Size and Forecast, by Product
      • 16.6.11.3 South Africa Market Size and Forecast, by Services
      • 16.6.11.4 South Africa Market Size and Forecast, by Technology
      • 16.6.11.5 South Africa Market Size and Forecast, by Component
      • 16.6.11.6 South Africa Market Size and Forecast, by Application
      • 16.6.11.7 South Africa Market Size and Forecast, by Device
      • 16.6.11.8 South Africa Market Size and Forecast, by Process
      • 16.6.11.9 South Africa Market Size and Forecast, by End User
      • 16.6.11.10 Local Competition Analysis
      • 16.6.11.11 Local Market Analysis
    • 16.6.1 Rest of MEA
      • 16.6.12.1 Rest of MEA Market Size and Forecast, by Type
      • 16.6.12.2 Rest of MEA Market Size and Forecast, by Product
      • 16.6.12.3 Rest of MEA Market Size and Forecast, by Services
      • 16.6.12.4 Rest of MEA Market Size and Forecast, by Technology
      • 16.6.12.5 Rest of MEA Market Size and Forecast, by Component
      • 16.6.12.6 Rest of MEA Market Size and Forecast, by Application
      • 16.6.12.7 Rest of MEA Market Size and Forecast, by Device
      • 16.6.12.8 Rest of MEA Market Size and Forecast, by Process
      • 16.6.12.9 Rest of MEA Market Size and Forecast, by End User
      • 16.6.12.10 Local Competition Analysis
      • 16.6.12.11 Local Market Analysis

17: Competitive Landscape

  • 17.1 Overview
  • 17.2 Market Share Analysis
  • 17.3 Key Player Positioning
  • 17.4 Competitive Leadership Mapping
    • 17.4.1 Star Players
    • 17.4.2 Innovators
    • 17.4.3 Emerging Players
  • 17.5 Vendor Benchmarking
  • 17.6 Developmental Strategy Benchmarking
    • 17.6.1 New Product Developments
    • 17.6.2 Product Launches
    • 17.6.3 Business Expansions
    • 17.6.4 Partnerships, Joint Ventures, and Collaborations
    • 17.6.5 Mergers and Acquisitions

18: Company Profiles

  • 18.1 BrainStorm Cell Therapeutics
    • 18.1.1 Company Overview
    • 18.1.2 Company Snapshot
    • 18.1.3 Business Segments
    • 18.1.4 Business Performance
    • 18.1.5 Product Offerings
    • 18.1.6 Key Developmental Strategies
    • 18.1.7 SWOT Analysis
  • 18.2 Mitsubishi Tanabe Pharma Corporation
    • 18.2.1 Company Overview
    • 18.2.2 Company Snapshot
    • 18.2.3 Business Segments
    • 18.2.4 Business Performance
    • 18.2.5 Product Offerings
    • 18.2.6 Key Developmental Strategies
    • 18.2.7 SWOT Analysis
  • 18.3 Orphazyme
    • 18.3.1 Company Overview
    • 18.3.2 Company Snapshot
    • 18.3.3 Business Segments
    • 18.3.4 Business Performance
    • 18.3.5 Product Offerings
    • 18.3.6 Key Developmental Strategies
    • 18.3.7 SWOT Analysis
  • 18.4 AB Science
    • 18.4.1 Company Overview
    • 18.4.2 Company Snapshot
    • 18.4.3 Business Segments
    • 18.4.4 Business Performance
    • 18.4.5 Product Offerings
    • 18.4.6 Key Developmental Strategies
    • 18.4.7 SWOT Analysis
  • 18.5 MediciNova
    • 18.5.1 Company Overview
    • 18.5.2 Company Snapshot
    • 18.5.3 Business Segments
    • 18.5.4 Business Performance
    • 18.5.5 Product Offerings
    • 18.5.6 Key Developmental Strategies
    • 18.5.7 SWOT Analysis
  • 18.6 Biogen
    • 18.6.1 Company Overview
    • 18.6.2 Company Snapshot
    • 18.6.3 Business Segments
    • 18.6.4 Business Performance
    • 18.6.5 Product Offerings
    • 18.6.6 Key Developmental Strategies
    • 18.6.7 SWOT Analysis
  • 18.7 Ionis Pharmaceuticals
    • 18.7.1 Company Overview
    • 18.7.2 Company Snapshot
    • 18.7.3 Business Segments
    • 18.7.4 Business Performance
    • 18.7.5 Product Offerings
    • 18.7.6 Key Developmental Strategies
    • 18.7.7 SWOT Analysis
  • 18.8 Cytokinetics
    • 18.8.1 Company Overview
    • 18.8.2 Company Snapshot
    • 18.8.3 Business Segments
    • 18.8.4 Business Performance
    • 18.8.5 Product Offerings
    • 18.8.6 Key Developmental Strategies
    • 18.8.7 SWOT Analysis
  • 18.9 Amylyx Pharmaceuticals
    • 18.9.1 Company Overview
    • 18.9.2 Company Snapshot
    • 18.9.3 Business Segments
    • 18.9.4 Business Performance
    • 18.9.5 Product Offerings
    • 18.9.6 Key Developmental Strategies
    • 18.9.7 SWOT Analysis
  • 18.10 Apellis Pharmaceuticals
    • 18.10.1 Company Overview
    • 18.10.2 Company Snapshot
    • 18.10.3 Business Segments
    • 18.10.4 Business Performance
    • 18.10.5 Product Offerings
    • 18.10.6 Key Developmental Strategies
    • 18.10.7 SWOT Analysis
  • 18.11 Anelixis Therapeutics
    • 18.11.1 Company Overview
    • 18.11.2 Company Snapshot
    • 18.11.3 Business Segments
    • 18.11.4 Business Performance
    • 18.11.5 Product Offerings
    • 18.11.6 Key Developmental Strategies
    • 18.11.7 SWOT Analysis
  • 18.12 Treeway
    • 18.12.1 Company Overview
    • 18.12.2 Company Snapshot
    • 18.12.3 Business Segments
    • 18.12.4 Business Performance
    • 18.12.5 Product Offerings
    • 18.12.6 Key Developmental Strategies
    • 18.12.7 SWOT Analysis
  • 18.13 Genervon Biopharmaceuticals
    • 18.13.1 Company Overview
    • 18.13.2 Company Snapshot
    • 18.13.3 Business Segments
    • 18.13.4 Business Performance
    • 18.13.5 Product Offerings
    • 18.13.6 Key Developmental Strategies
    • 18.13.7 SWOT Analysis
  • 18.14 NeuroSense Therapeutics
    • 18.14.1 Company Overview
    • 18.14.2 Company Snapshot
    • 18.14.3 Business Segments
    • 18.14.4 Business Performance
    • 18.14.5 Product Offerings
    • 18.14.6 Key Developmental Strategies
    • 18.14.7 SWOT Analysis
  • 18.15 QurAlis
    • 18.15.1 Company Overview
    • 18.15.2 Company Snapshot
    • 18.15.3 Business Segments
    • 18.15.4 Business Performance
    • 18.15.5 Product Offerings
    • 18.15.6 Key Developmental Strategies
    • 18.15.7 SWOT Analysis